Fig. 2
From: Recent advances in targeted therapies in acute myeloid leukemia
Updates in WHO/ICC MDS-defining genetic alterations in AML. Venn diagrams depict overlapping and distinct MDS-defining cytogenetic alterations A and somatic mutations B determined by the WHO [23] and ICC [24] Green text with arrows denotes overlapping entities with minor differences, black text denotes completely overlapping entities, and red text denotes completely distinct entities. MDS Myelodysplastic syndrome WHO World Health Organization, ICC International Consensus Classification